✦ LIBER ✦

Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors

✍ Scribed by Morgillo, Floriana; D’Aiuto, Elena; Troiani, Teresa; Martinelli, Erika; Cascone, Tina; De Palma, Raffaele; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato

Book ID: 119320413
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 894 KB
Volume: 71
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2010.06.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of Acquired Resistance to Epi

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

✍ Engelman, J. A.; Janne, P. A. 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

Acquired resistance mechanisms to tyrosi

Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny

✍ Suda, Kenichi; Mizuuchi, Hiroshi; Maehara, Yoshihiko; Mitsudomi, Tetsuya 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 398 KB

Primary and Acquired Resistance to Epide

Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

✍ Ayoola, Ayodele; Barochia, Amit; Belani, Kiran; Belani, Chandra P. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 403 KB

Acquired resistance to epidermal growth

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins

✍ Remon, J.; Morán, T.; Majem, M.; Reguart, N.; Dalmau, E.; Márquez-Medina, D.; Li 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Management of acquired resistance to epi

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer

✍ Sacher, Adrian G.; Jänne, Pasi A.; Oxnard, Geoffrey R. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

EKB-569, a new irreversible epidermal gr

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

✍ Yoshimura, Naruo; Kudoh, Shinzoh; Kimura, Tatsuo; Mitsuoka, Shigeki; Matsuura, K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB